Skip to content
★ Sign in to follow
Balaxi Pharmaceuticals Limited logo

Balaxi Pharmaceuticals Limited Stock: price and insider trades · India

IN·Mcap ₹1.2BHealth Care

Balaxi Pharmaceuticals Limited: what insiders have been doing

Only a handful of insider records exist for Balaxi Pharmaceuticals Limited, the last one from 12 April 2024, too few to describe a trend. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,661 of 26,914 companies
30.3
score / 100
Value
25
Quality
36
FCF yld-39%
Earn yld1.2%
EV/EBITDA15.7x
ROE0.6%
Gross mgn44%
Net mgn0.5%
Debt/EBITDA5.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹21.76
Analyst consensus
·
Income statement
Revenue₹2.7B
Gross profit₹1.2B44% margin
EBITDA₹113.5M4% margin
Net income₹14.2M0.5% margin
Valuation
PER (trailing)48.4x
P/Book0.5x
Beta0.70
Balance sheet & cash
Market cap₹1.2B
Total debt₹576.5M
Free Cash Flow-₹473.5M
Debt / Equity23%
Profitability & ownership
ROE0.6%
ROA1.2%
Last declaration on 12 April 2024
Declarations9 total
  • ●
    Executives
    17M INR4SEBI
    50,000 shares@ ₹338.2518.3% of flowEquity SharesSEBI:92fd1f63de1b9e9d9a0d23c220ec20b8e5768e30
  • ●
    Executives
    5M INR3SEBI
    16,000 shares@ ₹338.255.8% of flowEquity SharesSEBI:09448de6c6ec637ff48fcd9b01b7b2eae94ce07e
  • ●
    Executives
    2M INR0SEBI
    5,000 shares@ ₹338.2536.1% of flowWarrantsSEBI:5d9e4656eceefa8975abcdab7c479c61849462d1
  • ●
    Executives
    23M INR0SEBI
    67,000 shares@ ₹338.2524.4% of flowWarrantsSEBI:afcefca1dd0e9b7a11e0f484200c90ae063e4e89
  • ●
    Executives
    23M INR4SEBI
    67,000 shares@ ₹338.2524.2% of flowEquity SharesSEBI:58a9c61775c1c2fe7d09ec72fdbce2926552cd69
  • ●
    Executives
    2M INR6SEBI
    5,000 shares@ ₹338.2536.7% of flowEquity SharesSEBI:8719626a56b4072f3dc6f0018a6659d669240304
  • ●
    Executives
    1M INR0SEBI
    10,000 shares@ ₹112.7527.2% of flowWarrantsSEBI:ac2fd0330cd6735a2ed34fa17f87ac02c529a755
  • ●
    Executives
    0SEBI
    0Equity SharesSEBI:37e5efec6bc5e747f9b3cce3fa19eafd1a16a9cc
  • ●
    Executives
    23M INR0SEBI
    200,000 shares@ ₹112.7527.3% of flowWarrantsSEBI:4308dc4543e270b48567a459318f2368c0b0fe40

9 of 9 declarations

About Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited is a company focused on the health and pharmaceutical sector. It is listed on the XBOM.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations